Klippel-Trenaunay Syndrome (KTS) is a rare congenital disorder characterized by abnormal development of certain blood vessels, soft tissues (including skin and muscles), bones, and occasionally the lymphatic system. It is usually identified at birth and presents with distinctive features such as a port-wine stain birthmark, which can range from pink to reddish-purple in color, abnormal formations in veins or the lymphatic system, and the overgrowth of tissues and bones. Although these symptoms primarily affect one leg, they can also manifest in an arm or other parts of the body. While there is no cure for KTS, treatments are available to help manage its symptoms. Health professionals typically detect and diagnose KTS shortly after birth, and prompt treatment can mitigate the risk of further health issues associated with the condition.
Klippel-Trenaunay Syndrome (KTS) is characterized by a distinctive set of symptoms and complications, primarily affecting the skin, veins, soft tissues, bones, and the lymphatic system.
The primary features include:
Complications associated with KTS include:
Additional Congenital Differences: Though less common, some individuals with KTS might have congenital differences in their hands or toes, such as extra fingers or toes (polydactyly) or fused fingers or toes (syndactyly).
While Klippel-Trenaunay syndrome (KTS) can be hereditary, not all cases are inherited. The condition is typically caused by genetic alterations or mutations, with the PIK3CA gene being most commonly implicated. This gene plays a crucial role in tissue formation and cell proliferation within the body. Mutations in the PIK3CA gene lead to tissue overgrowth. These genetic alterations occur randomly during early development, specifically before birth, during cell division.
It is unlikely that parents of one child with KTS would have another child with the medical conditions, even if one of the parents has KTS. Family history does not appear to be a risk factor.